Navigation Links
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
Date:4/9/2008

S. Securities and Exchange Commission) will be available at no charge from the U.S. Securities and Exchange Commission through its website at http://www.sec.gov. Investors and security holders may also obtain free copies of the documents filed with the U.S. Securities and Exchange Commission by Millennium at http://www.millennium.com .

Investor Contacts: Media Contacts:

Seizo Masuda (Takeda) Matt Kuhn (Takeda)

(011-81) 3-3278-2037 (224) 554-5609

masuda_seizo@takeda.co.jp mkuhn@tpna.com

Kyle Kuvalanka (Millennium) Karen Gobler (Millennium)

(617) 761-4734 (617) 444-1392

kyle.kuvalanka@mpi.com karen.gobler@mpi.com


'/>"/>
SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. PPD Confirms Takedas NDA Filing of Alogliptin with U.S. Food and Drug Administration
2. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
3. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
4. VWR International, LLC Acquires Jencons (Scientific) Ltd, UK
5. Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the Peoples Republic of China
6. Aida Acquires High-Level Research Institute in China
7. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
8. China Aoxing Pharmaceutical Company Signed Definitive Acquisition Agreement to Acquire Shijiazhuang Lerentang Pharmaceutical Company, Ltd.
9. Immucor To Acquire BioArray Solutions Ltd.
10. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
11. Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Thomson Reuters today ... the first drug pipeline database to fully integrate ... highly anticipated new content is being provided to ... ,, Thomson Pharma will offer drug ... releases, conferences, and other sources across all therapeutic ...
(Date:12/15/2009)... Office has announced the launch of several innovative new ... services in the current economic climate. The first ... to finance legal services over a period of 6, ... in their start-up companies. The second is aimed ... payment arrangements over 6 to 12 month period at ...
(Date:12/14/2009)... 14 Vermillion, Inc. (Pink Sheets: ... William C. Wallen, Ph.D. Chief Scientific Officer, ... IDEXX Laboratories, will be joining its board ... plan. ,, "Bill brings more than ... diagnostics and biotechnology," said Gail Page, Vermillion ...
(Date:12/14/2009)... Patrick Kennedy Joins with State Biotech Leaders ... in Research and Development while Boosting Rhode ... ,, PROVIDENCE, R.I., Dec. 14 /PRNewswire-USNewswire/ ... leaders in research, medicine and biotechnology gathered ... to discuss the importance of medical innovation ...
Breaking Biology Technology:Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4
... Cephalon, Inc. (Nasdaq:,CEPH) today communicated with healthcare ... and administration for FENTORA(R),(fentanyl buccal tablet) [C-II]. ... medical community to reinforce the appropriate prescribing ... issued in collaboration with the U.S. Food ...
... (Nasdaq: EXEL ) today announced the closing of ... net proceeds of the,offering are approximately $71.8 million, after ... offering are being sold by,Exelixis. Exelixis has also granted ... additional 1,050,000 shares of common stock. Goldman,Sachs & Co. ...
... and government organizations will gather for 3rd Annual Personalized ... produced by Burrill Life Sciences Media ... future a,trip to the doctor,s office will be a radically ... genetic profile information about,predisposition to disease, the appropriate remedial therapies, ...
Other Biology Technology:Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA 2Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA 3Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA 4Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA 5The 3rd Annual Burrill Personalized Medicine Meeting November 12-13, 2007 in San Francisco 2
(Date:12/14/2009)... A team of researchers from the Astrobiology Centre (INTA-CSIC) ... considered essential to the formation of the most basic ... blue. In order to carry out this study, published ... scientists recreated the chemical conditions of the early Earth. ... dissolved in ammoniac solutions it produces hydrogen cyanide, a ...
(Date:12/14/2009)... Pa., Dec. 14 MODA Technology Partners, ... (EM), utility and product testing for the Pharmaceutical ... 3.0, the company,s third generation mobile data acquisition ... organizations to further automate their regulated manufacturing processes. ... capabilities: ,, Fully-Configurable Test Methods: ...
(Date:12/13/2009)... a question about how a popular class of ... that reveal previously hidden components of chemical communication ... hallucinations characterize the illness, people with schizophrenia also ... a particular order, difficulties that interfere with their ... said Lee Schroeder, a student in the medical ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2New biosensors reveal workings of anti-psychotic drugs in the living brain 2Ohio Congressional Members Urge U S to Provide GM Retirees Medical Benefits 50205 1Ohio Congressional Members Urge U S to Provide GM Retirees Medical Benefits 50205 2Ohio Congressional Members Urge U S to Provide GM Retirees Medical Benefits 50205 3OncoGenex Pharmaceuticals Files Shelf Registration Statement 12807 1OncoGenex Pharmaceuticals Files Shelf Registration Statement 12807 2OncoGenex Pharmaceuticals Files Shelf Registration Statement 12807 3OncoGenex Pharmaceuticals Files Shelf Registration Statement 12807 4The Psychology of Celebrity Worship 50198 1The Psychology of Celebrity Worship 50198 2The Psychology of Celebrity Worship 50198 3
... as how their brains operate, a study at the University ... "Social Emotion and the Brain," at the annual meeting of ... first to use fMRI scans to study the connections between ... Combining fMRI scans with data relevant to social behavior is ...
... into coral disease, red tides and other marine ... chemicals as a source for pharmaceuticals. These chemicals ... and may be usable in human health care. ... Ocean Service, The Medical University of South Carolina ...
... AAAS Symposium, "Emerging Threats and Research Challenges for ... , William Laurance, senior staff scientist at ... recently co-organized a major event, "Debating the Tropical ... History in Washington, which was featured in the ...
Other Biology News:Researchers shed new light on connection between brain and loneliness 2Researchers shed new light on connection between brain and loneliness 3Breaking the barrier: Discovery of anti-resistance factors and novel ocean drugs 2Breaking the barrier: Discovery of anti-resistance factors and novel ocean drugs 3AAAS Symposium: Emerging threats to tropical, temperate and ocean ecosystems 2